Jennifer M. Specht, MD
Dr. Jennifer Specht is a medical oncologist at SCCA. She received her medical and fellowship training at University of Washington School of Medicine and Fred Hutchinson Cancer Research Center. She is an assistant professor at UW in the Medical Oncology division and specializes in treating breast cancer.
“As our scientific understanding of breast cancer advances, treatment options for patients become increasingly complex,” Dr. Specht says. “As a medical oncologist, my role is to provide patients with state-of-the-art recommendations for their treatment; integrating the best science with the unique needs of each patient. I support patient participation in well-designed clinical trials to answer important scientific questions about breast cancer, which ultimately leads to better health and longer life for cancer patients.”
Jennifer M. Specht, MD
Dr. Specht is a medical oncologist who specializes in treating women with breast cancer.Patient Care Philosophy:
As our scientific understanding of breast cancer advances, treatment options for patients become increasingly complex. As a medical oncologist, my role is to provide patients with state-of-the-art recommendations for their treatment; integrating the best science with the unique needs of each patient. I support patient participation in well-designed clinical trials to answer important scientific questions about breast cancer, which ultimately leads to better health and longer life for cancer patients.
Title
- Medical Oncology Division, Assistant Professor, University of Washington Medical Center
Clinical Expertise
Breast Cancer Genetics, Investigational Breast Cancer Treatments
Education And Training
- Medical School: University of Washington, 1999
- Residency: Internal Medicine, University of Washington, 1999-2002
- Fellowship: University of Washington / Fred Hutchinson Cancer Research Center, 2002-2005
More Information
For more information about Dr. Jennifer M. Specht's clinical and research expertise, click here.Clinical Trials
- Triple Negative (6628)
- Expanded Access Protocol of Iniparib in Combination with Gemcitabine/Carboplatin (20100374) (UW100009)
- Pertuzumab in Combination With Herceptin and Vinorelbine for Metastatic or HER2-Positive Breast Cancer (UW12012)
- The BEACON Study-Breast Cancer Outcomes With NKTR-102 (UW11054)
